Business
Counterpart Health 2025 Results: How Better Clinical Decisions at Scale Improve Outcomes, Quality, and Cost
Counterpart continues to demonstrate that unified data and real-time insights, delivered directly into the clinician’s workflow, drive measurable clinical and financial outcomesSAN FRANCISCO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart” or the “Company”), a leading AI-powered physician-enablement platform and subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV), today released key 2025 highlights. The past year was defined by continued publication of researc
About this update from Clover Health Investments, Corp.
[{"type":"image","alt":"Clover Health Investments, Corp.","displaySize":"","headline":null,"caption":"Clover Health Investments, Corp.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":69,"url":"https://media.zenfs.com/en/globenewswire.com/5220c2eec2b7aec2d58005b5a05e9207"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/1HrSYo.eR7ZNai2k9C6CsA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTk3O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/5220c2eec2b7aec2d58005b5a05e9207","width":300,"height":69}},"lazy":false},{"type":"text","content":"Counterpart continues to demonstrate that unified data and real-time insights, delivered directly into the clinician’s workflow, drive measurable clinical and financial outcomes","length":177,"tagName":"p"},{"type":"text","content":"SAN FRANCISCO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart” or the “Company”), a leading AI-powered physician-enablement platform and subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV), today released key 2025 highlights. The past year was defined by continued publication of research demonstrating the platform's impact on chronic disease management, meaningful product expansion, and the scaled adoption of Counterpart Assistant (CA) by hundreds of live third-party customer clinicians across diverse practice settings.","length":565,"tagName":"p"},{"type":"text","content":"Clinical Quality and Financial Performance Outcomes","length":51,"tagName":"p"},{"type":"text","content":"Data released in 2025 highlights the scale and consistency of the platform's impact. These outcomes reflect the cumulative effect of thousands of better clinical decisions made during real patient visits:","length":208,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Clinician Adoption: Counterpart recorded a >450% Year-over-Year increase in live third-party customer clinicians, now representing hundreds of third-party customer clinicians live on the platform across multiple states.","length":222,"tagName":"p"}]},{"val":[{"type":"text","content":"MCR Differential: Returning Clover Health members whose primary care physicians (PCPs) use CA demonstrated an approximate 1,500 basis point MCR differential compared to those whose PCPs do not, with performance differentials compounding as member cohorts mature.","length"...